Brainstorm Cell Therapeutics Inc. (BCLI) SEC Filings — 2024
26 SEC filings for Brainstorm Cell Therapeutics Inc. (BCLI) in 2024.
Filings
- Brainstorm Cell Therapeutics Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Nov 14, 2024
- Brainstorm Cell Therapeutics Q3 2024 Update — 10-Q · Nov 14, 2024
- Brainstorm Cell Therapeutics Inc. SC 13G Filing — SC 13G · Nov 13, 2024
- Brainstorm Cell Therapeutics Faces Delisting Concerns — 8-K · Oct 30, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Oct 1, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Sep 26, 2024
- Brainstorm Cell Therapeutics Files 8-K with Corporate Updates — 8-K · Sep 16, 2024
- Brainstorm Cell Therapeutics Files Definitive Proxy Statement — DEF 14A · Aug 16, 2024
- Brainstorm Cell Therapeutics Files 8-K on Financials — 8-K · Aug 14, 2024
- Brainstorm Cell Therapeutics Q2 2024 Financial Update — 10-Q · Aug 14, 2024
- Brainstorm Cell Therapeutics Files 8-K on Shareholder Nominations — 8-K · Jul 30, 2024
- Brainstorm Cell Therapeutics Faces Delisting Notice — 8-K · Jul 19, 2024
- Brainstorm Cell Therapeutics Files 8-K with Key Agreements — 8-K · Jun 28, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Jun 26, 2024
- Brainstorm Cell Therapeutics Files 8-K on Leadership Changes — 8-K · Jun 20, 2024
- Brainstorm Cell Therapeutics Faces Delisting Notice — 8-K · Jun 4, 2024
- BRAINSTORM CELL THERAPEUTICS INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Brainstorm Cell Therapeutics Faces Delisting Concerns — 8-K · May 3, 2024
- Brainstorm Cell Therapeutics Announces Board Changes and New CMO — 8-K · Apr 17, 2024
- Brainstorm Cell Therapeutics CFO Resigns, Interim Appointed — 8-K · Apr 11, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Apr 9, 2024
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Apr 2, 2024
- Brainstorm Cell Therapeutics Files 8-K on Financials — 8-K · Apr 1, 2024
- BRAINSTORM CELL THERAPEUTICS INC. Files 2023 10-K — 10-K · Apr 1, 2024
- Kevin D. Ness Discloses 9.9% Stake in Brainstorm Cell Therapeutics — SC 13G/A · Feb 12, 2024